Literature DB >> 16172197

Molecular analysis of the androgen receptor gene in testicular cancer.

A Garolla1, A Ferlin, C Vinanzi, A Roverato, G Sotti, W Artibani, C Foresta.   

Abstract

Testicular cancer (TC) is the most common solid tumour in white males aged 20-34 years, and its incidence has doubled over the past 40 years. Some risk factors for TC have been proposed, such as cryptorchidism, infertility and testicular dysgenesis. However, the causes of TC remain still largely unknown. Recently a genetic basis for TC has been proposed, but specific genetic alterations have not been identified. The risk of TC is markedly increased in subjects with androgen insensitivity and some authors have suggested that mutations in the androgen receptor (AR) gene or disorders of CAG and GGC repeats could be related to TC. However, definitive data have not been produced. In this study, we analysed the AR gene for mutations and CAG and GGC triplets in exon 1 in 123 patients affected by TC. In three patients (2.3%) we found a mutation in the AR gene, two of which represent a novel mutation. Evaluation of CAG and GGC repeat numbers showed no difference with respect to controls when these variables were analysed separately. However, when joint distributions of CAG and GGC were considered, we found that the combination CAG=20/GGC=17 was significantly more frequent in TC patients (8.1%) with respect to controls (1.7%, P<0.05). Furthermore, we observed that in TC subjects, differently from controls, the joint analysis of CAG and GGC showed a statistically significant dependence among these variable repeats. In conclusion, our data show for the first time a high prevalence of AR gene mutations in patients affected by TC and suggest that some CAG/GGC combinations might be more frequently associated with an increased risk of TC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172197     DOI: 10.1677/erc.1.00954

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  17 in total

Review 1.  Local signalling environments and human male infertility: what we can learn from mouse models.

Authors:  Roopa L Nalam; Martin M Matzuk
Journal:  Expert Rev Mol Med       Date:  2010-05-11       Impact factor: 5.600

2.  Is there any clinical relevant difference between non mosaic Klinefelter Syndrome patients with or without Androgen Receptor variations?

Authors:  Umberto Valente; Cinzia Vinanzi; Savina Dipresa; Riccardo Selice; Massimo Menegazzo; Massimo Iafrate; Carlo Foresta; Andrea Garolla
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

Review 3.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

4.  Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types.

Authors:  Carol A Davis-Dao; Kimberly D Siegmund; David J Vandenberg; Eila C Skinner; Gerhard A Coetzee; Duncan C Thomas; Malcolm C Pike; Victoria K Cortessis
Journal:  Carcinogenesis       Date:  2011-06-03       Impact factor: 4.944

5.  The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.

Authors:  Sarmistha Mukherjee; Osvaldo Cruz-Rodríguez; Eric Bolton; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

6.  Isolated micropenis reveals partial androgen insensitivity syndrome confirmed by molecular analysis.

Authors:  Amrit Bhangoo; Francoise Paris; Pascal Philibert; Francoise Audran; Svetlana Ten; Charles Sultan
Journal:  Asian J Androl       Date:  2010-03-22       Impact factor: 3.285

7.  Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk.

Authors:  John Charles A Lacson; Joshua D Carroll; Ellenie Tuazon; Esteban J Castelao; Leslie Bernstein; Victoria K Cortessis
Journal:  Cancer       Date:  2012-09-10       Impact factor: 6.860

8.  Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors.

Authors:  Pei Dong; Zhuo-Wei Liu; Xiang-Dong Li; Yong-Hong Li; Kai Yao; Song Wu; Zi-Ke Qin; Hui Han; Fang-Jian Zhou
Journal:  Med Oncol       Date:  2013-02-12       Impact factor: 3.064

9.  Genetic variants in the 8q24 locus and risk of testicular germ cell tumors.

Authors:  Michael B Cook; Barry I Graubard; Sabah M Quraishi; Meredith Yeager; Stephen J Chanock; Andrew Crenshaw; Ralph L Erickson; Mark V Rubertone; Gilles Thomas; Katherine A McGlynn
Journal:  Hum Genet       Date:  2008-03-29       Impact factor: 4.132

Review 10.  Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility.

Authors:  Niels E Skakkebaek; Ewa Rajpert-De Meyts; Germaine M Buck Louis; Jorma Toppari; Anna-Maria Andersson; Michael L Eisenberg; Tina Kold Jensen; Niels Jørgensen; Shanna H Swan; Katherine J Sapra; Søren Ziebe; Lærke Priskorn; Anders Juul
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.